Director, Division of Clinical Safety and Surveillance, OSCE, OGD, CDER, FDA, United States
Dr. Chazin joined FDA in 2002 and has held several leadership positions related to clinical policy and safety of new drugs, biologics and generics. He is the Director of the Division of Clinical Safety and Surveillance in the Office of Generic Drugs' Office of Safety and Clinical...
Read More →AK
Associate Professor of Medicine, Brigham and Women's Hospital/Harvard Medical School
Dr. Kesselheim is an internist, lawyer, and faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. Within the Division, Aaron created and leads the Program On Regulation, Therapeutics, And Law (www.PORTALresearch.org), an interdisciplinary...
Read More → KK
Senior Vice President, Global Regulatory Affairs, Apotex Inc
Kiran Krishnan is Senior Vice President, Global Regulatory Affairs at Apotex Corp., located in Weston, Florida. He has 18 years of experience in the generic pharmaceutical industry. Kiran's areas of expertise include formulation development, process development, validation, intellectual...
Read More →